CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
GlaxoSmithKline plc Company Snapshot
GlaxoSmithKline plc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline plc with three other pharmaceutical manufacturers in Europe: Bayer AG of Germany (2017 sales of 35.02 billion Euro [US$40.81 billion] of which 48% was Pharmaceuticals & Biological Products), Sanofi S.A. of France (36.20 billion Euro [US$42.20 billion] of which 83% was Pharmaceuticals), and Novartis AG which is based in Switzerland (49.16 billion Swiss Francs [US$49.16 billion] of which 66% was Innovative Medicines).

Sales Analysis. During the year ended December of 2017, sales at GlaxoSmithKline plc were £30.19 billion (US$39.61 billion). This is an increase of 8.2% versus 2016, when the company's sales were £27.89 billion. This was the third consecutive year of growth at GlaxoSmithKline plc. Sales of Vaccines saw an increase of 12.4% in 2017, from £4.59 billion to £5.16 billion.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
GlaxoSmithKline plc
  Stock Performance Chart for GlaxoSmithKline plc
 
  Stock Data: Recent Stock Performance:
  Current Price (7/13/2018): 1,576.00p
(Figures in Pounds Sterling)
1 Week 1.8%   13 Weeks 1.3%  
4 Weeks 11.0%   52 Weeks -2.0%  
 
GlaxoSmithKline plc Key Data:
  Ticker: GSK Country: United Kingdom
  Exchanges: DUS FRA LON OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 30,186,000,000
(Year Ending Jan 2018).
Employees: 98,462
  Currency: Pounds Sterling Market Cap: 78,153,246,210
  Fiscal Yr Ends: December Shares Outstanding: 4,958,962,323
  Share Type: Ordinary Closely Held Shares: 57,119,421
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.